Normal view MARC view ISBD view

Obesity and kidney disease: Beyond the hyperfiltration.

MedStar author(s):

Citation: International Journal of Immunopathology & Pharmacology. 29(3):354-63, 2016 SepPMID: 27044633Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): EditorialSubject headings: *Kidney Diseases/et [Etiology] | *Obesity/co [Complications] | Adipose Tissue/pa [Pathology] | Diabetes Mellitus, Type 2/ge [Genetics] | Humans | Hypertension/et [Etiology] | Overweight/co [Complications] | Risk FactorsYear: 2016 ISSN:

0394-6320

Name of journal: International journal of immunopathology and pharmacologyAbstract: Copyright (c) The Author(s) 2016.In industrialized countries, overweight and obesity account for approximately 13.8% and 24.9% of the kidney disease observed in men and women, respectively. Moreover, obesity-associated glomerulopathy is now considered as "an emerging epidemic." Kidney function can be negatively impacted by obesity through several mechanisms, either direct or indirect. While it is well established that obesity represents the leading risk factor for type 2 diabetes and hypertension, awareness that obesity is associated with direct kidney damage independently of hypertension and diabetes is still not widespread. In this paper we will discuss the emerging role of adipose tissue, particularly in the visceral depot, in obesity-induced chronic kidney damage. All authors: Campia U, Cardillo C, Di Daniele N, Franzese O, Lauro D, Mascali A, Nistico S, Tesauro MFiscal year: FY2017Digital Object Identifier:

https://dx.doi.org/10.1177/0394632016643550

Date added to catalog: 2017-04-11

Holdings ( 1 )
Title notes ( 3 )

Holdings
Item type	Current library	Collection	Call number	Status	Date due	Barcode
Journal Article	MedStar Authors Catalog	Article	27044633	Available		27044633

In industrialized countries, overweight and obesity account for approximately 13.8% and 24.9% of the kidney disease observed in men and women, respectively. Moreover, obesity-associated glomerulopathy is now considered as "an emerging epidemic." Kidney function can be negatively impacted by obesity through several mechanisms, either direct or indirect. While it is well established that obesity represents the leading risk factor for type 2 diabetes and hypertension, awareness that obesity is associated with direct kidney damage independently of hypertension and diabetes is still not widespread. In this paper we will discuss the emerging role of adipose tissue, particularly in the visceral depot, in obesity-induced chronic kidney damage.

English